External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study
Mauro Borzio(Ospedale Papa Giovanni XXIII), Fabio Fornari(Azienda Unità Sanitaria Locale Piacenza), Anna Toldi(Ospedale Valduce), Mario Mitra(Azienda di Rilievo Nazionale ed Alta Specializzazione), Rodolfo Sacco, Susanna Vicari(Presidenza Del Consiglio Dei Ministri), Massimo Marignani(Sapienza University of Rome), Andrea Salmi(Fondazione Poliambulanza Istituto Ospedaliero), Emanuela Bertolini(Hôpital d'Hautepierre), Giampiero Francica(Presidio Ospedaliero), Giancarlo Parisi(Ospedale Santa Maria), Sergio Boccia(Arcispedale Sant'Anna), Angelo Rossini(Centro Universitário Barão de Mauá), Ilario de Sio(University of Campania "Luigi Vanvitelli"), Anna Giacomin(Policlinico Universitario di Catania), E. Dionigi
Cited by 49
Related Papers
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133
Anticoagulant treatment in COVID-19: a narrative review
|Journal of Thrombosis and Thrombolysis|2020|111
Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study
|The American Journal of Gastroenterology|2002|80
The impact of infection by multidrug‐resistant agents in patients with cirrhosis. A multicenter prospective study
|Liver International|2016|76
Acute torsion of uterine leiomyoma: CT features
|Abdominal Imaging|2004|74